ArticleCancer cell2023

Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy.

Mark Jesus M Magbanua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.